Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsLiver TransplantationGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationWhole-Body IrradiationKidney TransplantationBone and BonesAnemia, AplasticTransplantation ConditioningLeukemiaImmunosuppressive AgentsGraft RejectionTransplantation ChimeraTissue DonorsGraft SurvivalHeart TransplantationBusulfanBone Marrow PurgingHistocompatibility TestingTreatment OutcomeHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesRetrospective StudiesTime FactorsHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteRemission InductionHematologic NeoplasmsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationLeukocyte TransfusionLymphoma, Non-HodgkinAcute DiseaseSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensSurvival AnalysisMyelodysplastic SyndromesLung TransplantationProspective StudiesCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectCell DifferentiationGraft vs Leukemia EffectFollow-Up StudiesCytarabineLeukocyte CountSurvival RateCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaCells, CulturedFatal OutcomeAntigens, CD34Hodgkin DiseaseMice, KnockoutPrognosisInfectionCell TransplantationGranulocytes